Davis Andrew has filed 13 insider transactions across 1 company since February 2023.
Most recent transaction: a sale of 5360 shares of IRONWOOD PHARMACEUTICALS INC ($IRWD) on November 18, 2024.
Activity breakdown: 0 open-market purchases and 7 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 18, 2024 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Davis Andrew | SVP, Chief Business Officer | S | Class A Common Stock | 5360 | $4.08 | 284,685.0000 | 160,232,000 | 1.85% | 0.00% |
| May 20, 2024 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Davis Andrew | SVP, Chief Business Officer | S | Class A Common Stock | 22725 | $6.45 | 288,031.0000 | 157,700,000 | 7.31% | 0.01% |
| March 8, 2024 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Davis Andrew | SVP, Chief Business Officer | M | Class A Common Stock | 37120 | $0.00 | 310,756.0000 | 155,435,000 | 13.57% | 0.02% |
| March 8, 2024 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Davis Andrew | SVP, Chief Business Officer | M | Performance-based Restricted Stock Unit | 37120 | $0.00 | 0.0000 | 155,435,000 | 100.00% | 0.02% |
| Feb. 12, 2024 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Davis Andrew | SVP, Chief Business Officer | S | Class A Common Stock | 9846 | $15.24 | 208,324.0000 | 155,435,000 | 4.51% | 0.01% |
| Feb. 12, 2024 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Davis Andrew | SVP, Chief Business Officer | A | Class A Common Stock | 65312 | $0.00 | 273,636.0000 | 155,435,000 | 31.35% | 0.04% |
| Feb. 12, 2024 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Davis Andrew | SVP, Chief Business Officer | A | Performance-based Restricted Stock Unit | 32656 | $0.00 | 32,656.0000 | 155,435,000 | 9999.99% | 0.02% |
| Nov. 20, 2023 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Davis Andrew | SVP, Chief Business Officer | S | Class A Common Stock | 3287 | $9.69 | 217,374.0000 | 186,891,000 | 1.49% | 0.00% |
| May 22, 2023 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Davis Andrew | SVP, Chief Business Officer | S | Class A Common Stock | 6305 | $10.12 | 219,327.0000 | 186,680,000 | 2.79% | 0.00% |
| March 8, 2023 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Davis Andrew | SVP, Chief Business Officer | A | Class A Common Stock | 74236 | $0.00 | 225,632.0000 | 186,312,000 | 49.03% | 0.04% |
| March 8, 2023 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Davis Andrew | SVP, Chief Business Officer | A | Performance-based Restricted Stock Units | 37118 | $0.00 | 37,118.0000 | 186,312,000 | 9999.99% | 0.02% |
| Feb. 27, 2023 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Davis Andrew | SVP, Chief Business Officer | S | Class A Common Stock | 1751 | $11.41 | 153,218.0000 | 186,312,000 | 1.13% | 0.00% |
| Feb. 28, 2023 | IRONWOOD PHARMACEUTICALS INC | $IRWD | Davis Andrew | SVP, Chief Business Officer | S | Class A Common Stock | 1822 | $11.31 | 151,396.0000 | 186,312,000 | 1.19% | 0.00% |